U

Ultralight

Streamlines medical device compliance platform

Overview

Ultralight Labs builds a lightweight, cloud-based platform for medical device teams to manage regulatory compliance. It integrates requirements management, risk assessment, and end-to-end traceability into one easy-to-use system, helping engineering, quality, and regulatory staff collaborate and stay compliant without slowing development. The product is offered on a subscription basis, providing ongoing updates and support. Unlike heavier, complex compliance tools, Ultralight Labs focuses on speed and simplicity to reduce time, cost, and friction in getting medical devices to market. The company's goal is to accelerate medical device innovation by making critical compliance workflows faster and easier to manage.

Work here?Claim your company

About Ultralight

Simplify's Rating
Why Ultralight is rated
C+
Rated C on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & AnalyticsEnterprise SoftwareHealthcare

Company Size

1-10

Company Stage

Seed

Total Funding

$2.7M

Headquarters

New York City, New York

Founded

2022

Get referred to Ultralight

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • Greenlight Guru says Ultralight now reaches 1,000-plus medical device companies.
  • The acquisition gives Ultralight distribution, regulatory expertise, and cross-sell leverage immediately.
  • Updated October 2026 pages show active product integration and continued branding support.

What critics are saying

  • Ultralight no longer exists independently; Greenlight Guru controls strategy, hiring, and roadmap.
  • Consolidation signals product overlap risk with Greenlight Guru and Enzyme through 2026.
  • Differentiation shrinks if Ultralight’s simplicity becomes a feature inside a larger suite.

What makes Ultralight unique

  • Ultralight’s medtech workflows targeted early-stage SiMD and SaMD teams.
  • Its pitch centered on fast requirements, risk, and traceability tooling for regulated builds.
  • Greenlight Guru folded Ultralight into a broader lifecycle platform on June 17, 2025.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$2.7M

Below

Industry Average

Funded Over

1 Rounds

Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Below Average

Industry standards

$3.3M
$2M
$2.3M
$2.7M
$3M

Company News

Wilson Sonsini Goodrich & Rosati
Apr 13th, 2026
Ultralight raises $9.3M for AI-native operating system transforming modern medicine

Ultralight, an AI-native operating system for modern medicine, has raised $9.3 million in seed funding led by The General Partnership. Wisdom Ventures, Anthemis Group, Emerson Collective, GSBackers and various angel investors participated in the round. The platform automates administrative tasks and provides clinical insights for functional, integrative and longevity practices. Ultralight unifies electronic health records, practice management and patient engagement in a single vertical SaaS stack with integrated AI capabilities. Wilson Sonsini Goodrich & Rosati advised Ultralight on the transaction, with Lang Liu and Oliver Zhou leading the team.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Ultralight right now.

Find jobs on Simplify and start your career today

We update Ultralight's jobs every few hours, so check again soon!Browse all jobs